Paradiso PR - Search Results

1

Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old.

Paradiso PR, Hildreth SW, Hogerman DA, Speelman DJ, Lewin EB, Oren J, Smith DH. Paradiso PR, et al. Pediatr Infect Dis J. 1994 Sep;13(9):792-8. doi: 10.1097/00006454-199409000-00008. Pediatr Infect Dis J. 1994. PMID: 7808848 Clinical Trial.

2

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

Tristram DA, Welliver RC, Mohar CK, Hogerman DA, Hildreth SW, Paradiso P. Tristram DA, et al. J Infect Dis. 1993 Jan;167(1):191-5. doi: 10.1093/infdis/167.1.191. J Infect Dis. 1993. PMID: 8418166 Clinical Trial.

3

Mapping of a fusion related epitope of the respiratory syncytial virus fusion protein.

Paradiso PR, Hu BT, Arumugham R, Hildreth S. Paradiso PR, et al. Vaccine. 1991 Apr;9(4):231-7. doi: 10.1016/0264-410x(91)90105-f. Vaccine. 1991. PMID: 1711741

4

Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization.

Hildreth SW, Baggs RR, Brownstein DG, Castleman WL, Paradiso PR. Hildreth SW, et al. Among authors: paradiso pr. Vaccine. 1993;11(6):615-8. doi: 10.1016/0264-410x(93)90304-g. Vaccine. 1993. PMID: 8322482

5

Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia.

Groothuis JR, King SJ, Hogerman DA, Paradiso PR, Simoes EA. Groothuis JR, et al. Among authors: paradiso pr. J Infect Dis. 1998 Feb;177(2):467-9. doi: 10.1086/517377. J Infect Dis. 1998. PMID: 9466539 Clinical Trial.

6

Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement.

Tristram DA, Welliver RC, Hogerman DA, Hildreth SW, Paradiso P. Tristram DA, et al. Vaccine. 1994 May;12(6):551-6. doi: 10.1016/0264-410x(94)90316-6. Vaccine. 1994. PMID: 8036830 Clinical Trial.

7

Expression of the F glycoprotein gene from human respiratory syncytial virus in Escherichia coli: mapping of a fusion inhibiting epitope.

Martin-Gallardo A, Fien KA, Hu BT, Farley JF, Seid R, Collins PL, Hildreth SW, Paradiso PR. Martin-Gallardo A, et al. Among authors: paradiso pr. Virology. 1991 Sep;184(1):428-32. doi: 10.1016/0042-6822(91)90863-7. Virology. 1991. PMID: 1714666

8

Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV).

Murphy BR, Prince GA, Collins PL, Hildreth SW, Paradiso PR. Murphy BR, et al. Among authors: paradiso pr. Vaccine. 1991 Mar;9(3):185-9. doi: 10.1016/0264-410x(91)90151-u. Vaccine. 1991. PMID: 2042390

9

Antigenic structure of the fusion glycoprotein of respiratory syncytial virus.

Paradiso PR, Hu B, Hildreth S, Martin A, Arumugham R. Paradiso PR, et al. Adv Exp Med Biol. 1989;251:273-8. doi: 10.1007/978-1-4757-2046-4_25. Adv Exp Med Biol. 1989. PMID: 2481965 No abstract available.

10

Interprotein disulfide bonding between F and G glycoproteins of human respiratory syncytial virus.

Arumugham RG, Hildreth SW, Paradiso PR. Arumugham RG, et al. Among authors: paradiso pr. Arch Virol. 1989;105(1-2):65-79. doi: 10.1007/BF01311117. Arch Virol. 1989. PMID: 2719556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters